{"id":1207,"date":"2022-07-31T17:35:00","date_gmt":"2022-07-31T15:35:00","guid":{"rendered":"http:\/\/docsites.cgmlife.com\/brodnicek\/?page_id=1207"},"modified":"2022-12-11T18:57:16","modified_gmt":"2022-12-11T16:57:16","slug":"covid-preockovani-rousky","status":"publish","type":"page","link":"https:\/\/docsites.cgmlife.com\/brodnicek\/covid-preockovani-rousky\/","title":{"rendered":"Covid – p\u0159eo\u010dkov\u00e1n\u00ed, rou\u0161ky"},"content":{"rendered":"
<\/div>\n
Z\u00e1jemci o p\u0159eo\u010dkov\u00e1n\u00ed druhou posilovac\u00ed d\u00e1vkou<\/strong><\/span> se mohou nechat o\u010dkovat v\u00a0o\u010dkovac\u00edm centru Oblastn\u00ed nemocnice P\u0159\u00edbram<\/a><\/div>\n
Vakc\u00edna Valneva nen\u00ed pro p\u0159eo\u010dkov\u00e1n\u00ed k dispozici.<\/div>\n
<\/div>\n
P\u0159ed rozhodnut\u00edm o p\u0159eo\u010dkov\u00e1n\u00ed v\u00e1m doporu\u010dujeme zv\u00e1\u017eit n\u00e1sleduj\u00edc\u00ed skute\u010dnosti:<\/div>\n
___
\n<\/span><\/div>\n
1) imunita po prod\u011blan\u00e9m onemocn\u011bn\u00ed zpravidla chr\u00e1n\u00ed velmi v\u00fdrazn\u011b a dlouhodob\u011b p\u0159ed v\u00e1\u017en\u00fdm pr\u016fb\u011bhem onemocn\u011bn\u00ed, hospitalizac\u00ed a \u00famrt\u00edm, (2<\/a>,3<\/a>,9<\/a>,12<\/a>)<\/div>\n
2) o\u010dkov\u00e1n\u00ed poskytuje ochranu proti v\u00e1\u017en\u00e9mu pr\u016fb\u011bhu lidem, kte\u0159\u00ed je\u0161t\u011b covid nem\u011bli, ale tato ochrana je n\u00e1sobn\u011b men\u0161\u00ed ne\u017e ochrana poskytovan\u00e1 d\u0159\u00edv\u011bj\u0161\u00edm prod\u011bl\u00e1n\u00edm nemoci,\u00a0(2<\/a>,3<\/a>,9<\/a>,12<\/a>)<\/div>\n
3) p\u0159edpokl\u00e1dan\u00e1 \u00fa\u010dinnost posilovac\u00ed d\u00e1vky je kr\u00e1tk\u00e1 (2-3 m\u011bs\u00edce)\u00a0(1<\/a>)<\/div>\n
4) lid\u00e9, kte\u0159\u00ed ji\u017e covid prod\u011blali, jsou proti v\u00e1\u017en\u00e9mu pr\u016fb\u011bhu onemocn\u011bn\u00ed chr\u00e1n\u011bni do takov\u00e9 m\u00edry, \u017ee o\u010dkov\u00e1n\u00ed jim dal\u0161\u00ed dodate\u010dnou ochranu neposkytne\u00a0(12<\/span><\/a>)<\/span><\/div>\n
5) riziko ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f po o\u010dkov\u00e1n\u00ed nen\u00ed zanedbateln\u00e9 a roste s ka\u017edou dal\u0161\u00ed d\u00e1vkou, (2<\/span><\/a>,4<\/span><\/a>,6<\/span><\/a>,7<\/span><\/a>,8<\/span><\/a>)<\/span><\/div>\n
6) nejv\u00edc nemocn\u00fdch osob je aktu\u00e1ln\u011b mezi o\u010dkovan\u00fdmi, (2<\/span><\/a>,3<\/span><\/a>,9<\/span><\/a>,11<\/span><\/a>)<\/span><\/div>\n
7) p\u0159eo\u010dkov\u00e1n\u00ed je vhodn\u00e9 jen pro rizikov\u00e9 osoby a v\u017edy je t\u0159eba posuzovat p\u0159\u00ednosy a rizika,\u00a0\u00a0(1<\/span><\/a>,2<\/span><\/a>)<\/span><\/div>\n
8) u mlad\u0161\u00edch zdrav\u00fdch osob je p\u0159\u00ednos o\u010dkov\u00e1n\u00ed minim\u00e1ln\u00ed,\u00a0\u00a0(2<\/span><\/a>)<\/span><\/div>\n
9) ochrana o\u010dkov\u00e1n\u00edm proti infekci je kr\u00e1tkodob\u00e1 v \u0159\u00e1du 2-3 m\u011bs\u00edc\u016f,\u00a0(2<\/span><\/a>,3<\/span><\/a>)<\/span><\/div>\n
10) velmi vysok\u00fd pod\u00edl o\u010dkovan\u00fdch osob v nemocnic\u00edch nasv\u011bd\u010duje tomu, \u017ee ochrana o\u010dkov\u00e1n\u00edm p\u0159ed hospitalizac\u00ed je omezen\u00e1, (9<\/span><\/a>,11<\/span><\/a>)<\/span><\/div>\n
11) chyb\u00ed dlouhodob\u00e1 data z klinick\u00fdch studi\u00ed, ve kter\u00fdch byly kontroln\u00ed skupiny zni\u010deny t\u00edm, \u017ee byly po kr\u00e1tk\u00e9 dob\u011b nao\u010dkov\u00e1ny.\u00a0(10<\/span><\/a>)<\/span><\/div>\n
___
\n<\/span><\/div>\n
Zakladatel \u010desk\u00e9 imunologie a st\u00e1le praktikuj\u00edc\u00ed l\u00e9ka\u0159 MUDr. Jaroslav Svoboda na dotaz ohledn\u011b dal\u0161\u00edch d\u00e1vek odpov\u00edd\u00e1: „Osobn\u011b jako klinik nevid\u00edm nejmen\u0161\u00edho d\u016fvodu k nov\u00e9 vakcinaci proti jak\u00e9si neexistuj\u00edc\u00ed nov\u00e9 variant\u011b nov\u00e9ho koronaviru. A\u0165 u\u017e jsme byli o\u010dkov\u00e1ni nebo ne, minim\u00e1ln\u011b s variantou Omicron, kter\u00e1 je jakousi obecnou vakc\u00ednou proti koronaviru, jsme se setkali snad v\u0161ichni (p\u0159edchoz\u00ed varianty – wuhansk\u00e1, britsk\u00e1 alpha,…, indick\u00e1 delta – chr\u00e1nily p\u0159edev\u0161\u00edm proti pouze t\u00e9 kter\u00e9 variant\u011b). Nyn\u00ed se setk\u00e1v\u00e1me u Omicronu s nov\u00fdmi subvariantami, kterou jsou pravd\u011bpodobn\u011b infek\u010dn\u011bj\u0161\u00ed, ale nevyvol\u00e1vaj\u00ed odli\u0161n\u00fd klinick\u00fd stav, tj. 2 – 3 dny teplota a m\u00edrn\u00fd respira\u010dn\u00ed infekt, p\u0159\u00edpadn\u011b tuto infekci ani nezaregistrujeme. V\u00fdjimkou jsou t\u011b\u017ece imunodeficientn\u00ed lid\u00e9 \u00a0– je t\u0159eba p\u0159ed rozhodnut\u00edm z\u00edskat informaci o obou z\u00e1kladn\u00edch typech imunity… Snad pouze v takov\u00fdch p\u0159\u00edpadech je indikov\u00e1na vakcinace klasickou sofistikovanou vakc\u00ednou firem Valneva nebo Novavax.\u201c<\/div>\n
o___<\/span><\/div>\n

Rou\u0161ky nebo respir\u00e1tory<\/strong><\/span> nejsou v na\u0161\u00ed ordinaci povinn\u00e9. Nebyl prok\u00e1z\u00e1n vliv jejich plo\u0161n\u00e9ho pou\u017e\u00edv\u00e1n\u00ed na pokles p\u0159enosu infekce.\u00a0(5)<\/span><\/a><\/span> <\/strong>Pokud se v\u0161ak v rou\u0161ce nebo respir\u00e1toru c\u00edt\u00edte bezpe\u010dn\u011bji, jist\u011b je m\u016f\u017eete pou\u017e\u00edt. Pokud jste nachlazeni, m\u00e1te ka\u0161el a teplotu, je jejich pou\u017eit\u00ed v\u00fdrazem ohleduplnosti v\u016f\u010di jin\u00fdm pacient\u016fm.<\/p>\n

1) \u010ctvrt\u00e1 d\u00e1vka v \u010dervenci nen\u00ed dobr\u00fd n\u00e1pad. Na podzim se to m\u016f\u017ee vymst\u00edt<\/span><\/a><\/span><\/div>\n
2) Koment\u00e1\u0159 k doporu\u010den\u00edm \u010cesk\u00e9 vakcinologick\u00e9 spole\u010dnosti \u010cLSJEP ze dne 16. \u010dervna 2022<\/span><\/a><\/span><\/div>\n
3) Imunita z\u00edskan\u00e1 po prod\u011blan\u00e9 infekci chr\u00e1n\u00ed p\u0159ed opakovan\u00fdm onemocn\u011bn\u00edm covid-19 a hospitalizac\u00ed<\/span><\/a><\/span><\/div>\n
4) Ne\u017e\u00e1douc\u00ed \u00fa\u010dinky po o\u010dkov\u00e1n\u00ed na covid-19<\/span><\/a><\/span><\/div>\n
5) Sou\u010dasn\u00fd pohled na p\u0159\u00ednos no\u0161en\u00ed respir\u00e1tor\u016f jako ochrann\u00e9ho prost\u0159edku p\u0159ed infekc\u00ed<\/span><\/a><\/span><\/div>\n
6) V\u011bdec apeluje na zastaven\u00ed dal\u0161\u00edch d\u00e1vek o\u010dkov\u00e1n\u00ed a studium ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f<\/span><\/a><\/span><\/div>\n
7) Co \u0159\u00edkaj\u00ed l\u00e9ka\u0159i americk\u00e9 arm\u00e1dy?<\/span><\/a><\/span><\/div>\n
8) Odpov\u011b\u010f ministerstva obrany na \u00fanik z datab\u00e1ze DMED<\/span><\/a><\/span><\/div>\n
9)\u00a0Chr\u00e1n\u00ed n\u00e1s o\u010dkov\u00e1n\u00ed p\u0159ed infekc\u00ed a t\u011b\u017ek\u00fdm pr\u016fb\u011bhem covid-19? – Sdru\u017een\u00ed mikrobiolog\u016f, imunolog\u016f a statistik\u016f | SMIS (smis-lab.cz)<\/span><\/a><\/span><\/div>\n
10) Canadian Covid Care Alliance<\/span><\/a> (Odkaz na obr\u00e1zek)<\/span><\/a><\/span><\/div>\n
11) Srovn\u00e1n\u00ed o\u010dkovan\u00ed \u00d7 neo\u010dkovan\u00ed | COVID o\u010dkov\u00e1n\u00ed (opendatalab.cz)<\/span><\/a><\/span><\/div>\n
12) Prod\u011bl\u00e1n\u00ed nemoci a ochrana p\u0159ed v\u00e1\u017en\u00fdm pr\u016fb\u011bhem reinfekce<\/span><\/a><\/span><\/div>\n
<\/div>\n","protected":false},"excerpt":{"rendered":"

Z\u00e1jemci o p\u0159eo\u010dkov\u00e1n\u00ed druhou posilovac\u00ed d\u00e1vkou se mohou nechat o\u010dkovat v\u00a0o\u010dkovac\u00edm centru Oblastn\u00ed nemocnice P\u0159\u00edbram Vakc\u00edna Valneva nen\u00ed pro p\u0159eo\u010dkov\u00e1n\u00ed k dispozici. P\u0159ed rozhodnut\u00edm o p\u0159eo\u010dkov\u00e1n\u00ed v\u00e1m doporu\u010dujeme zv\u00e1\u017eit n\u00e1sleduj\u00edc\u00ed skute\u010dnosti: ___ 1) imunita po prod\u011blan\u00e9m onemocn\u011bn\u00ed zpravidla chr\u00e1n\u00ed velmi v\u00fdrazn\u011b a dlouhodob\u011b p\u0159ed v\u00e1\u017en\u00fdm pr\u016fb\u011bhem onemocn\u011bn\u00ed, hospitalizac\u00ed a \u00famrt\u00edm, (2,3,9,12) 2) o\u010dkov\u00e1n\u00ed poskytuje ochranu […]<\/p>\n","protected":false},"author":626,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1207","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/docsites.cgmlife.com\/brodnicek\/wp-json\/wp\/v2\/pages\/1207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/docsites.cgmlife.com\/brodnicek\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/docsites.cgmlife.com\/brodnicek\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/docsites.cgmlife.com\/brodnicek\/wp-json\/wp\/v2\/users\/626"}],"replies":[{"embeddable":true,"href":"https:\/\/docsites.cgmlife.com\/brodnicek\/wp-json\/wp\/v2\/comments?post=1207"}],"version-history":[{"count":57,"href":"https:\/\/docsites.cgmlife.com\/brodnicek\/wp-json\/wp\/v2\/pages\/1207\/revisions"}],"predecessor-version":[{"id":1303,"href":"https:\/\/docsites.cgmlife.com\/brodnicek\/wp-json\/wp\/v2\/pages\/1207\/revisions\/1303"}],"wp:attachment":[{"href":"https:\/\/docsites.cgmlife.com\/brodnicek\/wp-json\/wp\/v2\/media?parent=1207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}